KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Novavax (NVAX) Exchange Rate Effect: 2013-2025

Historic Exchange Rate Effect for Novavax (NVAX) over the last 12 years, with Sep 2025 value amounting to $658,000.

  • Novavax's Exchange Rate Effect fell 89.08% to $658,000 in Q3 2025 from the same period last year, while for Sep 2025 it was -$3.1 million, marking a year-over-year decrease of 152.85%. This contributed to the annual value of -$7.8 million for FY2024, which is 338.39% down from last year.
  • As of Q3 2025, Novavax's Exchange Rate Effect stood at $658,000, which was down 91.68% from $7.9 million recorded in Q2 2025.
  • Over the past 5 years, Novavax's Exchange Rate Effect peaked at $9.3 million during Q3 2023, and registered a low of -$10.7 million during Q4 2024.
  • Over the past 3 years, Novavax's median Exchange Rate Effect value was -$156,000 (recorded in 2024), while the average stood at $282,364.
  • Per our database at Business Quant, Novavax's Exchange Rate Effect tumbled by 2,311.52% in 2021 and then skyrocketed by 5,167.95% in 2025.
  • Novavax's Exchange Rate Effect (Quarterly) stood at $916,000 in 2021, then spiked by 365.39% to $4.3 million in 2022, then plummeted by 31.57% to $2.9 million in 2023, then plummeted by 467.40% to -$10.7 million in 2024, then plummeted by 89.08% to $658,000 in 2025.
  • Its last three reported values are $658,000 in Q3 2025, $7.9 million for Q2 2025, and -$930,000 during Q1 2025.